This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.
COTY vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
COTY vs. EL: Which Stock Is the Better Value Option?
Is EWCZ Fixing Its Overbuilt Network With Smarter Expansion?
by Zacks Equity Research
European Wax Center shifts from rapid growth to strategic pruning, closing underperformers and upgrading its site selection tools.
Should Value Investors Buy Coty (COTY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
European Wax Center Leans on Digital Ads-Will It Pay Off?
by Zacks Equity Research
EWCZ's digital-first marketing revamp is lowering acquisition costs and fueling new guest growth in 2025.
EWCZ Stock Skyrockets 54% in 3 Months: Is it Too Late to Buy?
by Swati Prasad
EWCZ is gaining ground, with rising profits, strong guest trends, and smart expansion plans fueling investor confidence.
Top Beauty and Cosmetics Stocks That May Drive Long-Term Growth
by Ansuiya Mohta
EL, COTY and ULTA are tapping AI, e-commerce, and clean beauty to ride the next wave of long-term industry growth.
EWCZ EBITDA Expansion Shows Early Wins: Can Margins Stay Strong?
by Zacks Equity Research
European Wax Center posts 7.2% EBITDA growth and margin gains, but timing boosts raise questions about long-term sustainability.
Helen of Troy Q1 Earnings Fall Short of Estimates, Sales Dip Y/Y
by Zacks Equity Research
HELE's first-quarter fiscal 2026 earnings and revenue miss reflect tariff disruptions, weak China sales and U.S. consumer trade-down pressure.
EWCZ Marketing Shift Shows Early Wins: Can Growth Reignite Fast?
by Zacks Equity Research
European Wax Center's digital-first marketing revamp is showing early gains as it eyes stronger traffic and sales in late 2025.
Are Investors Undervaluing Coty (COTY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights Estee Lauder, Coty and European Wax Center
by Zacks Equity Research
EL, COTY and EWCZ are navigating cosmetic sector headwinds with digital upgrades, innovation and growth strategies.
3 Cosmetic Stocks Holding Steady Despite Market Challenges
by Ansuiya Mohta
EL, COTY and EWCZ are defying cosmetics industry headwinds with innovation, digital growth and strategic focus.
Why Is Coty (COTY) Up 9% Since Last Earnings Report?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Beauty and Cosmetics Stocks That Could Be in Your Portfolio
by Ansuiya Mohta
Leading companies like COTY, ULTA and SBH are tapping tech, innovation and shifting trends to stay ahead in the fast-evolving beauty market.
Coty Trading Cheaper Than Industry: What's the Next Best Move?
by Zacks Equity Research
COTY appears undervalued relative to peers, with long-term growth potential driven by digital expansion and strategic initiatives, though near-term challenges suggest caution.
Don't Overlook Coty (COTY) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Examine the evolution of Coty's (COTY) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
COTY's Q3 Earnings Miss Due to Market Challenges and FX Headwinds
by Zacks Equity Research
Coty posts weak third-quarter fiscal 2025 results hit by foreign exchange headwinds and market uncertainty.
Compared to Estimates, Coty (COTY) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Coty (COTY) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Coty (COTY) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of -80% and 0.43%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Coty Set to Release Q3 Earnings: Key Insights for Investors
by Zacks Equity Research
COTY's fiscal third-quarter results are likely to reflect ongoing market pressures, FX headwinds and elevated A&CP, offset by prestige growth efforts.
Coty (COTY) Reports Next Week: What You Should Expect
by Zacks Equity Research
Coty (COTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Beauty and Cosmetics Stocks to Boost Your Portfolio
by Ansuiya Mohta
Leading beauty and cosmetics stocks like EL, COTY and ULTA are thriving on innovation, technological advancements and sustainability.
4 Cosmetic Stocks to Keep an Eye On Despite Market Challenges
by Ansuiya Mohta
Despite ongoing macroeconomic challenges, companies like EL, COTY, HELE and EWCZ remain well-positioned, backed by digital innovation and strategic brand initiatives.
Helen of Troy (HELE) Soars 10.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Helen of Troy (HELE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
How to Play Ulta Beauty Stock After a 17% Drop in Three Months
by Swati Prasad
ULTA's stock slump reflects category softness and rising costs, but its push in skincare, loyalty and digital may help spark a long-term recovery.